BioCardia Analysis
BioCardia is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of BioCardia delisted stock analysis is to determine its intrinsic value, which is an estimate of what BioCardia is worth, separate from its market price. There are two main types of BioCardia's stock analysis: fundamental analysis and technical analysis.
The BioCardia stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. BioCardia is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. BioCardia Stock trading window is adjusted to America/New York timezone.
BioCardia |
BioCardia Stock Analysis Notes
The company recorded a loss per share of 3.2. BioCardia had not issued any dividends in recent years. For more info on BioCardia please contact Peter Altman at 650 226 0120 or go to https://www.biocardia.com.BioCardia Investment Alerts
| BioCardia is not yet fully synchronised with the market data | |
| BioCardia has some characteristics of a very speculative penny stock | |
| BioCardia has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 477 K. Net Loss for the year was (11.57 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioCardia generates negative cash flow from operations |
BioCardia Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioCardia insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioCardia's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BioCardia insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Frost Phillip Md Et Al over six months ago Acquisition by Frost Phillip Md Et Al of 595238 shares of BioCardia at 1.68 subject to Rule 16b-3 | ||
Edward Gillis over six months ago Disposition of 30000 shares by Edward Gillis of BioCardia at 2.49 subject to Rule 16b-3 | ||
Allen Jim L. over six months ago Acquisition by Allen Jim L. of 2734 shares of BioCardia subject to Rule 16b-3 | ||
Blank Andrew Scott over six months ago Acquisition by Blank Andrew Scott of 12434 shares of BioCardia at 4.43 subject to Rule 16b-3 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BioCardia to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in BioCardia Stock
If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |